Vincent Corbel

Dr. Vincent Corbel

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NMNicolas Moiroux
Nicolas Moiroux
MGMarinely B. Gomez
Marinely B. Gomez
CPCédric Pennetier
Cédric Pennetier
EEEmmanuel Elanga
Emmanuel Elanga
ADArmel Djènontin
Armel Djènontin
VCVincent Corbel
Vincent Corbel
Background. Behavioral modification of malaria vectors in response to vector control methods is of great concern. We investigated whether full coverage of long-lasting insecticide-treated mosquito nets (LLINs) may induce a switch in biting behavior in Anopheles funestus, a major malaria vector in Africa. Methods. Human-landing collections were conducted indoor and outdoor in 2 villages (Lokohouè and Tokoli) in Benin before and 1 year and 3 years after implementation of universal LLIN coverage. Proportion of outdoor biting (POB) and median catching times (MCT) were compared. The resistance of A. funestus to deltamethrin was monitored using bioassays. Results. MCT of A. funestus switched from 2 am in Lokohoué and 3 am in Tokoli to 5 am after 3 years (Mann–Whitney U test, P < .0001). In Tokoli, POB increased from 45% to 68.1% (odds ratio = 2.55; 95 confidence interval = 1.72–3.78; P < .0001) 1 year after the universal coverage, whereas POB was unchanged in Lokohoué. In Lokohoué, however, the proportion of A. funestus that bites after 6 am was 26%. Bioassays showed no resistance to deltamethrin. Conclusions. This study provides evidence for a switch in malaria vectors’ biting behavior after the implementation of LLIN at universal coverage. These findings might have direct consequences for malaria control in Africa and highlighted the need for alternative strategies for better targeting malaria vectors.

6 December 2018 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
DRDavid Roiz
David Roiz
AWAnne L. Wilson
Anne L. Wilson
TSThomas W. Scott
Thomas W. Scott
DFDina M. Fonseca
Dina M. Fonseca
FJFrédéric Jourdain
Frédéric Jourdain
VCVincent Corbel
Vincent Corbel
Diseases caused by Aedes-borne viruses, such as dengue, Zika, chikungunya, and yellow fever, are emerging and reemerging globally. The causes are multifactorial and include global trade, international travel, urbanisation, water storage practices, lack of resources for intervention, and an inadequate evidence base for the public health impact of Aedes control tools. National authorities need comprehensive evidence-based guidance on how and when to implement Aedes control measures tailored to local entomological and epidemiological conditions. This review is one of a series being conducted by the Worldwide Insecticide resistance Network (WIN). It describes a framework for implementing Integrated Aedes Management (IAM) to improve control of diseases caused by Aedes-borne viruses based on available evidence. IAM consists of a portfolio of operational actions and priorities for the control of Aedes-borne viruses that are tailored to different epidemiological and entomological risk scenarios. The framework has 4 activity pillars: (i) integrated vector and disease surveillance, (ii) vector control, (iii) community mobilisation, and (iv) intra- and intersectoral collaboration as well as 4 supporting activities: (i) capacity building, (ii) research, (iii) advocacy, and (iv) policies and laws. IAM supports implementation of the World Health Organisation Global Vector Control Response (WHO GVCR) and provides a comprehensive framework for health authorities to devise and deliver sustainable, effective, integrated, community-based, locally adapted vector control strategies in order to reduce the burden of Aedes-transmitted arboviruses. The success of IAM requires strong commitment and leadership from governments to maintain proactive disease prevention programs and preparedness for rapid responses to outbreaks. Aedes aegypti and A. albopictus are mosquito species that thrive in towns and cities and can transmit viruses to humans that cause diseases, such as dengue, Zika, chikungunya, and yellow fever. The geographic range of human infection with these viruses is rapidly expanding globally. Even when preventative or therapeutic treatments are available to fight these diseases, controlling the mosquito vector will remain an important control option. We therefore developed a framework called IAM that offers decision-making guidance based on available evidence of effective control of Aedes at different levels of infestation and virus transmission risk. Our work aims to strengthen the capacity of countries at risk of and/or affected by these diseases and vectors so they will be better prepared for existing and emerging Aedes-borne disease threats.

1 August 2012 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
VCVincent Corbel
Vincent Corbel
MAMartin Akogbeto
Martin Akogbeto
GDGeorgia B Damien
Georgia B Damien
ADArmel Djenontin
Armel Djenontin
FCFabrice Chandre
Fabrice Chandre
MHMarie-Claire Henry
Marie-Claire Henry

25 September 2013 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
TCTheeraphap Chareonviriyaphap
Theeraphap Chareonviriyaphap
MBMichael J Bangs
Michael J Bangs
WSWannapa Suwonkerd
Wannapa Suwonkerd
MKMonthathip Kongmee
Monthathip Kongmee
VCVincent Corbel
Vincent Corbel
RNRatchadawan Ngoen-Klan
Ratchadawan Ngoen-Klan
Physiological resistance and behavioral responses of mosquito vectors to insecticides are critical aspects of the chemical-based disease control equation. The complex interaction between lethal, sub-lethal and excitation/repellent ('excito-repellent’) properties of chemicals is typically overlooked in vector management and control programs. The development of “physiological” resistance, metabolic and/or target site modifications, to insecticides has been well documented in many insect groups and disease vectors around the world. In Thailand, resistance in many mosquito populations has developed to all three classes of insecticidal active ingredients currently used for vector control with a majority being synthetic-derived pyrethroids. Evidence of low-grade insecticide resistance requires immediate countermeasures to mitigate further intensification and spread of the genetic mechanisms responsible for resistance. This can take the form of rotation of a different class of chemical, addition of a synergist, mixtures of chemicals or concurrent mosaic application of different classes of chemicals. From the gathered evidence, the distribution and degree of physiological resistance has been restricted in specific areas of Thailand in spite of long-term use of chemicals to control insect pests and disease vectors throughout the country. Most surprisingly, there have been no reported cases of pyrethroid resistance in anopheline populations in the country from 2000 to 2011. The precise reasons for this are unclear but we assume that behavioral avoidance to insecticides may play a significant role in reducing the selection pressure and thus occurrence and spread of insecticide resistance. The review herein provides information regarding the status of physiological resistance and behavioral avoidance of the primary mosquito vectors of human diseases to insecticides in Thailand from 2000 to 2011.

26 October 2009 in BMC Genomics
Verified
Journal Article
Open access
PDF file
SMSébastien Marcombe
Sébastien Marcombe
RPRodolphe William Poupardin
Rodolphe William Poupardin
FDFrederic Darriet
Frederic Darriet
SRStéphane Reynaud
Stéphane Reynaud
JBJulien Bonnet
Julien Bonnet
JDJean-Philippe David
Jean-Philippe David
Background: The yellow fever mosquitoAedes aegyptiis a major vector of dengue and hemorrhagic fevers, causing up to 100 million dengue infections every year. As there is still no medicine and efficient vaccine available, vector control largely based on insecticide treatments remains the only method to reduce dengue virus transmission. Unfortunately, vector control programs are facing operational challenges with mosquitoes becoming resistant to commonly used insecticides. Resistance ofAe. aegyptito chemical insecticides has been reported worldwide and the underlying molecular mechanisms, including the identification of enzymes involved in insecticide detoxification are not completely understood.Results: The present paper investigates the molecular basis of insecticide resistance in a population ofAe. aegypticollected in Martinique (French West Indies). Bioassays with insecticides on adults and larvae revealed high levels of resistance to organophosphate and pyrethroid insecticides. Molecular screening for common insecticide target-site mutations showed a high frequency (71%) of the sodium channel 'knock down resistance' (kdr) mutation. Exposing mosquitoes to detoxification enzymes inhibitors prior to bioassays induced a significant increased susceptibility of mosquitoes to insecticides, revealing the presence of metabolic-based resistance mechanisms. This trend was biochemically confirmed by significant elevated activities of cytochrome P450 monooxygenases, glutathione S-transferases and carboxylesterases at both larval and adult stages. Utilization of the microarrayAedes Detox Chipcontaining probes for all members of detoxification and other insecticide resistance-related enzymes revealed the significant constitutive over-transcription of multiple detoxification genes at both larval and adult stages. The over-transcription of detoxification genes in the resistant strain was confirmed by using real-time quantitative RT-PCR.Conclusion: These results suggest that the high level of insecticide resistance found inAe. aegyptimosquitoes from Martinique island is the consequence of both target-site and metabolic based resistance mechanisms. Insecticide resistance levels and associated mechanisms are discussed in relation with the environmental context of Martinique Island. These finding have important implications for dengue vector control in Martinique and emphasizes the need to develop new tools and strategies for maintaining an effective control ofAedesmosquito populations worldwide.

5 August 2009 in BMC Biology
Verified
Journal Article
Open access
PDF file
VCVincent Corbel
Vincent Corbel
Maria StankiewiczMaria Stankiewicz
Maria Stankiewicz
CPCédric Pennetier
Cédric Pennetier
DFDidier Fournier
Didier Fournier
JSJure Stojan
Jure Stojan
Bruno LapiedBruno Lapied
Bruno Lapied
N,N-Diethyl-3-methylbenzamide (deet) remains the gold standard for insect repellents. About 200 million people use it every year and over 8 billion doses have been applied over the past 50 years. Despite the widespread and increased interest in the use of deet in public health programmes, controversies remain concerning both the identification of its target sites at the olfactory system and its mechanism of toxicity in insects, mammals and humans. Here, we investigated the molecular target site for deet and the consequences of its interactions with carbamate insecticides on the cholinergic system.